X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Sterling Biotech with Merck Ltd - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STERLING BIOTECH vs MERCK LTD - Comparison Results

STERLING BIOTECH    Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

MERCK LTD 
   Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STERLING BIOTECH MERCK LTD STERLING BIOTECH/
MERCK LTD
 
P/E (TTM) x -1.6 33.2 - View Chart
P/BV x 0.1 3.7 1.7% View Chart
Dividend Yield % 0.0 0.8 -  

Financials

 STERLING BIOTECH   MERCK LTD
EQUITY SHARE DATA
    STERLING BIOTECH
Dec-13
MERCK LTD
Dec-16
STERLING BIOTECH/
MERCK LTD
5-Yr Chart
Click to enlarge
High Rs111,060 1.0%   
Low Rs3623 0.5%   
Sales per share (Unadj.) Rs26.8632.4 4.2%  
Earnings per share (Unadj.) Rs-15.045.7 -32.7%  
Cash flow per share (Unadj.) Rs-5.562.3 -8.8%  
Dividends per share (Unadj.) Rs011.00 0.0%  
Dividend yield (eoy) %01.3 0.0%  
Book value per share (Unadj.) Rs54.9388.8 14.1%  
Shares outstanding (eoy) m267.8716.60 1,613.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.31.3 19.5%   
Avg P/E ratio x-0.518.4 -2.5%  
P/CF ratio (eoy) x-1.313.5 -9.4%  
Price / Book Value ratio x0.12.2 5.9%  
Dividend payout %024.1 0.0%   
Avg Mkt Cap Rs m1,86213,969 13.3%   
No. of employees `0001.41.6 85.5%   
Total wages/salary Rs m5471,487 36.8%   
Avg. sales/employee Rs Th5,303.36,631.9 80.0%   
Avg. wages/employee Rs Th403.8939.2 43.0%   
Avg. net profit/employee Rs Th-2,959.0479.4 -617.2%   
INCOME DATA
Net Sales Rs m7,18110,498 68.4%  
Other income Rs m43242 17.6%   
Total revenues Rs m7,22310,741 67.3%   
Gross profit Rs m9471,135 83.4%  
Depreciation Rs m2,543276 923.1%   
Interest Rs m4,3770-   
Profit before tax Rs m-5,9311,102 -538.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-1,924343 -560.5%   
Profit after tax Rs m-4,007759 -527.9%  
Gross profit margin %13.210.8 121.9%  
Effective tax rate %32.431.1 104.2%   
Net profit margin %-55.87.2 -771.8%  
BALANCE SHEET DATA
Current assets Rs m14,3356,410 223.7%   
Current liabilities Rs m49,8098,828 564.2%   
Net working cap to sales %-494.0-23.0 2,144.2%  
Current ratio x0.30.7 39.6%  
Inventory Days Days40358 699.3%  
Debtors Days Days17138 444.5%  
Net fixed assets Rs m55,4321,406 3,941.4%   
Share capital Rs m268166 161.4%   
"Free" reserves Rs m13,9356,286 221.7%   
Net worth Rs m14,7016,455 227.8%   
Long term debt Rs m9,4780-   
Total assets Rs m73,9888,828 838.1%  
Interest coverage x-0.4NM-  
Debt to equity ratio x0.60-  
Sales to assets ratio x0.11.2 8.2%   
Return on assets %0.58.6 5.8%  
Return on equity %-27.311.8 -231.8%  
Return on capital %-6.417.1 -37.6%  
Exports to sales %25.98.3 312.8%   
Imports to sales %0.221.0 0.8%   
Exports (fob) Rs m1,860869 213.9%   
Imports (cif) Rs m122,209 0.6%   
Fx inflow Rs m1,860959 194.0%   
Fx outflow Rs m252,612 1.0%   
Net fx Rs m1,835-1,653 -111.0%   
CASH FLOW
From Operations Rs m1,7191,070 160.6%  
From Investments Rs m-3,148-750 419.9%  
From Financial Activity Rs m1,426-150 -951.9%  
Net Cashflow Rs m-3171 -2.0%  

Share Holding

Indian Promoters % 33.9 0.0 -  
Foreign collaborators % 0.0 51.8 -  
Indian inst/Mut Fund % 0.0 18.2 -  
FIIs % 9.9 1.0 990.0%  
ADR/GDR % 16.9 0.0 -  
Free float % 39.3 29.1 135.1%  
Shareholders   21,482 28,591 75.1%  
Pledged promoter(s) holding % 55.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STERLING BIOTECH With:   DR. DATSONS LABS  STRIDES SHASUN LTD  FDC LTD.  JUBILANT LIFE SCIENCES  BIOCON LTD  

Compare STERLING BIOTECH With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Marginally Down; Tata Steel Top Loser(09:30 am)

Asian stocks rose in morning trade on Monday, after the US's S&P 500 extended its winning streak on Friday to six days. Markets in the Greater China region remain closed for the Lunar New Year holiday.

Related Views on News

Galaxy Surfactants Ltd. (IPO)

Jan 27, 2018

Should you subscribe to the IPO of Galaxy Surfactants Ltd?

Tata Chem: Suspension of Haldia Operations Drag Bottomline Lower (Quarterly Results Update - Detailed)

Aug 17, 2017

Interruption at Haldia plant and fire at Lostock facility hits operations during the quarter.

Galaxy Surfactants Ltd. (IPO)

Jan 27, 2018

Should you subscribe to the IPO of Galaxy Surfactants Ltd?

Tata Chem: Suspension of Haldia Operations Drag Bottomline Lower (Quarterly Results Update - Detailed)

Aug 17, 2017

Interruption at Haldia plant and fire at Lostock facility hits operations during the quarter.

More Views on News

Most Popular

Here's What You Should Do in this Market Crash(The 5 Minute Wrapup)

Feb 6, 2018

The market correction has provided a golden opportunity to buy five high-quality safe stocks.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

When Small is Not Always Beautiful(Chart Of The Day)

Feb 6, 2018

Big companies enjoying tax deductions and exemptions have an edge over the small companies.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

STERLING BIOTECH SHARE PRICE


Feb 19, 2018 10:09 AM

TRACK STERLING BIOTECH

  • Track your investment in STERLING BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STERLING BIOTECH

STERLING BIOTECH 8-QTR ANALYSIS

COMPARE STERLING BIOTECH WITH

MARKET STATS